ISOLA, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 637
AS - Asia 176
EU - Europa 166
SA - Sud America 6
AF - Africa 4
OC - Oceania 1
Totale 990
Nazione #
US - Stati Uniti d'America 634
SG - Singapore 90
SE - Svezia 46
HK - Hong Kong 40
IT - Italia 30
CN - Cina 16
RU - Federazione Russa 14
CH - Svizzera 13
KR - Corea 13
BG - Bulgaria 11
DE - Germania 10
IE - Irlanda 10
BE - Belgio 9
FI - Finlandia 8
IN - India 6
BR - Brasile 5
NL - Olanda 5
TW - Taiwan 4
UA - Ucraina 4
AT - Austria 3
CA - Canada 3
SN - Senegal 3
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
GB - Regno Unito 1
IL - Israele 1
IR - Iran 1
PH - Filippine 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
VN - Vietnam 1
Totale 990
Città #
Fairfield 96
Singapore 82
Ashburn 57
Woodbridge 51
Seattle 46
Chandler 42
Hong Kong 40
Houston 38
Wilmington 36
Ann Arbor 31
Boardman 28
Cambridge 26
Princeton 18
Santa Clara 16
Trieste 16
Seoul 13
Columbus 11
Sofia 11
Bern 10
Dublin 10
Brussels 9
Jacksonville 8
Moscow 8
San Diego 7
Helsinki 6
Beijing 5
Pune 5
Zhongli District 4
Amsterdam 3
Dakar 3
Norwalk 3
Shanghai 3
Tolmezzo 3
Zurich 3
Bremen 2
Hefei 2
Lappeenranta 2
Los Angeles 2
Messina 2
Milan 2
Montreal 2
São Paulo 2
Vibo Valentia 2
Washington 2
Andover 1
Binangonan 1
Chongqing 1
Cleveland 1
Council Bluffs 1
Dallas 1
Frankfurt am Main 1
Guaratingueta 1
Haifa 1
Istanbul 1
João Câmara 1
Mauriti 1
Mumbai 1
Nuremberg 1
Prague 1
Redwood City 1
Tehran 1
Toronto 1
Udine 1
Vienna 1
Totale 788
Nome #
Low-dose rituximab in adult patients with primary immune thrombocytopenia 125
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice 100
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 99
Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant 96
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response 93
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 93
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 91
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura 73
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 72
Inter-reader agreement of the Prostate Imaging Quality (PI-QUAL) score: A bicentric study 51
Predicting lymphoma in Sjögren's syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording 42
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 41
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab 35
Intravitreal injections: a healthcare failure modes and effects analysis 22
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 20
Totale 1.053
Categoria #
all - tutte 4.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202069 0 0 0 0 0 0 0 0 34 16 4 15
2020/2021162 2 19 4 25 19 23 8 13 4 17 6 22
2021/2022122 5 13 0 4 1 1 8 3 26 10 8 43
2022/2023176 12 17 18 12 19 31 0 17 30 8 11 1
2023/2024153 14 13 11 6 17 26 19 14 13 1 18 1
2024/2025249 3 44 55 26 25 35 28 24 9 0 0 0
Totale 1.053